Quick Answer
ARROWHEAD PHARMACEUTICALS, INC. reported Total Assets of $1.39 billion for fiscal year 2025.
ARROWHEAD PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.39B | +21.5% |
| 2024 | $1.14B | +48.9% |
| 2023 | $765.55M | +10.6% |
| 2022 | $691.94M | -2.6% |
| 2021 | $710.15M | +35.9% |
| 2020 | $522.50M | +49.4% |
| 2019 | $349.85M | +213.5% |
| 2018 | $111.61M | +7.3% |
| 2017 | $104.02M | -18.8% |
| 2016 | $128.18M | -3.1% |
| 2015 | $132.27M | -27.7% |
| 2014 | $182.82M | +389.7% |
| 2013 | $37.33M | +125.9% |
| 2012 | $16.53M | +4.0% |
| 2011 | $15.89M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $1.60B | +58.3% | +15.8% |
| September 30, 2025 | $1.39B | +21.5% | +0.3% |
| June 30, 2025 | $1.38B | +56.2% | -12.3% |
| March 31, 2025 | $1.57B | +64.7% | +55.2% |
| December 31, 2024 | $1.01B | +61.9% | -11.1% |
| September 30, 2024 | $1.14B | +48.9% | +29.0% |
| June 30, 2024 | $883.76M | +11.0% | -7.5% |
| March 31, 2024 | $955.15M | +7.2% | +52.5% |
- ARROWHEAD PHARMACEUTICALS, INC. showed an increase of +21.5% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, ARROWHEAD PHARMACEUTICALS, INC.’s total assets has grown by 8618.8% (from $15.89 million to $1.39 billion).
- The most recent figure is from ARROWHEAD PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: